Association between MMP-2 gene polymorphism and cataract susceptibility: A protocol for systematic review and meta-analysis. Issue 14 (9th April 2021)

• Record Type: Journal Article
• Authors: Jiang, Huaiyan; Gao, Yang; Chen, Zhen; Xu, Hongxia
• Is Part Of: Medicine. Volume 100:Issue 14(2021)
• Publication Date: 2021-04-09
• Subjects: cataract -- matrix metalloproteinase-2 -- meta-analysis -- polymorphism -- protocol; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000025392
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Background: Matrix metalloproteinase-2 (MMP-2) polymorphisms have been considered as risk factors of cataracts, but the results still remain controversial. In this study, we have performed a systematic meta-analysis to evaluate the association between MMP-2 polymorphisms and cataract risks. Methods: Published literature was retrieved from Wanfang, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, Chongqing VIP Chinese Science and Technology Periodical Database, PubMed, Embase, and Web of Science databases. The case–control studies that explored the association between MMP-2 polymorphisms and cataract risks were included. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random- or fixed-effects model. Results: This study could provide high-quality and evidence-based medical evidence for the correlation between MMP-2 polymorphisms and cataract risks Conclusion: The study could provide updated evidence for the evaluation of the relationship between MMP-2 polymorphism and cataract risk. Ethics and dissemination: The private information from individuals will not be published. This systematic review also will not involve endangering participant rights. Ethical approval is not available. The results may be published in a peer-reviewed journal or disseminated in relevant conferences. OSF Registration Number: DOI 10.17605/OSF.IO/KU9NE.